CD8A and neoplasm: In addition, hyaluronan targeting using hyaluronidase has demonstrated efficacy in reducing tumor growth, limiting liver metastasis, and improving the effectiveness of ICI therapy by enhancing the infiltration of B and CD8+ T cells, including subsets with resident memory phenotypes, while mitigating immunosuppressive mechanisms [97].